Shanghai Henlius Biotech, Inc. Class H (HK:2696) has released an update.
Shanghai Henlius Biotech has announced the renewal of its Promotional Services Agreement with Jiangsu Fosun, extending the partnership for an additional year through 2025. This agreement involves promotional activities for their product HANQUYOU in various regions of China, with adjustments to fees and designated areas. The transactions are categorized as continuing connected transactions under the Listing Rules, necessitating reporting and review without requiring independent shareholder approval.
For further insights into HK:2696 stock, check out TipRanks’ Stock Analysis page.